Skip to main content
. Author manuscript; available in PMC: 2024 Apr 1.
Published in final edited form as: Gynecol Oncol. 2023 Feb 16;171:15–22. doi: 10.1016/j.ygyno.2023.01.037

Figure 3: Kaplan-Meyer estimate of overall survival for ECs by molecular subtype according to CD8+ infiltration defined by ssGSEA.

Figure 3:

ECs of CN-high, CN-low, and MSI-high molecular subtypes were stratified into CD8+ high (blue solid line) or CD8+ low (orange dashed line) defined by their distribution around the median CD8+ infiltration for the entire cohort (n=232) using ssGSEA. *Due to only 4 events in OS, no HR and p-value were reported for the CN-low cohort.